| |
| |
|
| Insider
Information: |
Al-Wakeel Yasir B. |
| Relationship: |
Chief Financial Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
346,102 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
346,102 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neon Therapeutics, Inc. |
NTGN |
Chief Financial Officer |
2020-05-06 |
0 |
2018-07-17 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Chief Financial Officer |
2023-07-06 |
346,102 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRON |
Kronos Bio, Inc. |
Chief Financial Officer |
• – – |
2023-07-06 |
4 |
S |
$1.75 |
$16,852 |
D/D |
(9,617) |
346,102 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Chief Financial Officer |
• – – |
2023-02-24 |
4 |
S |
$1.74 |
$15,665 |
D/D |
(9,026) |
355,719 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Chief Financial Officer |
• – – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
138,911 |
364,745 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Chief Financial Officer |
• – – |
2022-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
53,600 |
216,841 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Chief Financial Officer |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
53,600 |
163,241 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Chief Financial Officer |
• – – |
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
72,422 |
109,641 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Chief Financial Officer |
• – – |
2020-10-14 |
4 |
B |
$19.00 |
$99,750 |
D/D |
5,250 |
37,219 |
2.74 |
- |
|
| KRON |
Kronos Bio, Inc. |
Chief Financial OfficerOfficer |
• – – |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,969 |
|
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-05-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(196,965) |
0 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-02-29 |
4 |
D |
$1.50 |
$7,337 |
D/D |
(4,891) |
196,965 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-02-25 |
4 |
D |
$1.51 |
$8,131 |
D/D |
(5,385) |
201,856 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
207,241 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2019-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
142,241 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
67,241 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-07-17 |
4 |
OE |
$5.80 |
$99,998 |
D/D |
17,241 |
17,241 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
